Commercial Operations
CS MEDICA operates from the Danish headquarter and has contracts covering 25+ countries. The Nordics are essential markets for testing new products and building best practices for expansion. Our commercial team analyzes the demographics, competition, target segments’ behavior, level of CBD know-how, and registration windows to optimize the Go-to-Market strategy and choice of potential distributing partners.
The company’s BtBtC strategy is to benefit from the competitive advantage and to fast-track our market entry. Our treatments are available as OTC (over-the-counter) through pharmacies, drugstores, retail, clinics/hospitals, and online. We do this through the CANNASEN® brand or own-label option, split into white-label and private-label options. We support our partners with insights on how to market our treatments, define CBD as an ingredient, and frame the right local launch strategies, which is why we are transitioning from a BtB and BtC focus towards a BtBtC, with extended focus on MaaS (Marketing as a Service) and data. This approach secures the pace of growth while adapting to the demands of partners, key opinion leaders, and patients.
